Compare M&T Bank Corporation (MTB) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
M&T Bank Corporation vs Zoetis Inc — how do they compare? M&T Bank Corporation trades at $237.67 (market cap $34.43B), while Zoetis Inc trades at $73.7 (market cap $30.40B). The key difference: M&T Bank Corporation and Zoetis Inc are close in size by market cap, and Zoetis Inc pays the higher dividend (2.88%). Which is the better fit depends on your goals.
| MTB | ZTS | |
|---|---|---|
Market Cap | $34.43B | $30.40B |
Sector | Financials | Health |
52-Week High | $254.09 | $150.61 |
52-Week Low | $178.63 | $71.91 |
Dividend Yield | 2.52% | 2.88% |
Enterprise Value | — | $37.96B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MTB trades at $238.44, down 0.58% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported three consecutive quarterly EPS beats, with Q2 2026 EPS of $5.35 surpassing the $4.66 estimate. Revenue for 2025 reached $9.63 billion, with a net income margin of 30.85%. Recent news highlights participation in the Barclays Global Financial Services Conference and a declared quarterly dividend of $1.50 per share.
The outlook for MTB is supported by strong earnings performance and a consensus price target of $261.62, implying about 10% upside. However, risks include a negative net cash flow of -$2.01 billion in 2025 and elevated debt levels, with a debt-to-asset ratio of 6.09. Investor sentiment is mixed, with 31% of analysts rating it a buy but 60% recommending hold, reflecting caution amid macroeconomic pressures.
Zoetis (ZTS) trades at $73.60, down 2.92% amid bearish technical signals and mixed earnings. The stock faces pressure from weakening U.S. companion animal sales and competitive headwinds, though profitability remains strong with 71.67% gross margins and 27.69% net income margin. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a guidance cut. Analyst consensus is divided with 45% Buy ratings and a $93.40 price target, suggesting 27% upside from current levels.
The outlook balances valuation appeal (P/E of 12) against near-term operational challenges. Investment opportunity lies in market dominance and robust cash flow generation, while risks include sustained pet health demand softness and competitive pricing pressure. The stock trades near support at $73, with institutional sentiment mixed amid recent portfolio adjustments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
